(Q37905118)

25 August 2017

1 reference

title

Intraneuronal Aβ as a trigger for neuron loss: can this be translated into human pathology? (English)

1 reference

25 August 2017

0 references

Thomas A Bayer

1

1 reference

25 August 2017

Oliver Wirths

series ordinal

2

1 reference

25 August 2017

publication date

1 August 2011

1 reference

Biochemical Society Transactions

25 August 2017

published in

1 reference

25 August 2017

volume

39

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

857-861

1 reference

Amyloid deposition as the central event in the aetiology of Alzheimer's disease

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Alzheimer's disease: the amyloid cascade hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

The molecular pathology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Amyloid beta-peptide: the inside story

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Role of amyloid-beta glycine 33 in oligomerization, toxicity, and neuronal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Alzheimer's disease is a synaptic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

A Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

A specific amyloid-beta protein assembly in the brain impairs memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Structure-neurotoxicity relationships of amyloid beta-protein oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Amyloid-beta protofibril levels correlate with spatial learning in Arctic Alzheimer's disease transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Amyloid plaque core protein in Alzheimer disease and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Amyloidogenic processing of amyloid precursor protein: evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Identification of low molecular weight pyroglutamate A{beta} oligomers in Alzheimer disease: a novel tool for therapy and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

Active and passive immunotherapy for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390857

21 January 2018

Identifiers

DOI

10.1042/BST0390857

1 reference

25 August 2017

1 reference